Logo Image

Precision Medicine and Biologics

Latest News

December 23rd 2021
Secukinumab Receives FDA Approval for Pediatric Patients with PsA

Secukinumab is the only biologic treatment in the US that’s approved by the FDA for pediatric patients with enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA).

November 11th 2021

New Frontiers in Psoriatic Disease Research

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
September 23rd 2021

The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics

March 5th 2021

The Potential of Precision Medicine

CME Content

View More
Rethinking Dermatologic Care – Optimizing Dermatologic Outcomes With High-Efficacy Treatments and Proactive Management | Hollywood, FL
In-Person + Virtual Event

Rethinking Dermatologic Care – Optimizing Dermatologic Outcomes With High-Efficacy Treatments and Proactive Management | Hollywood, FL

November 15, 2026

View more
DermNexus: The Inflammatory Disease and Innovations Congress for NP/PAs
In-Person Event

DermNexus: The Inflammatory Disease and Innovations Congress for NP/PAs

November 20-21, 2026

Register now!
Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care
Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

View more
Publication Review: Defining On-Treatment Remission in Plaque Psoriasis
Video

Publication Review: Defining On-Treatment Remission in Plaque Psoriasis

April W. Armstrong, MD, MPH; Tina Bhutani-Jacques MD

View more